Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AB Enzymes
A16AB19 Pegvaliase
D11077 Pegvaliase (INN) <JP/US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Pegvaliase
D11077 Pegvaliase (INN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D11077 Pegvaliase (INN); Pegvaliase (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Other monooxygenases
PAH* [HSA_VAR:5053v1]
D11077 Pegvaliase (INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11077
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11077
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11077
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11077
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D11077